News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Drug discovery
IN PARTNERSHIP WITH ANIMA BIOTECH
Webinar: mRNA Is Never Naked, Exploring RBP Target Space & Therapeutic Opportunities
Watch this webinar to gain insights from expert speakers, Dr. Iris Alroy and Dr. Kristopher Brannan, who have made significant advancements in the field of RBPs.
November 14, 2023
·
2 min read
PRESS RELEASES
Press Releases
U.S. Roadside Drug Testing Market Size to Reach USD 2.28 Billion By 2033
October 9, 2024
·
1 min read
Press Releases
Nipro Launches D2F™ Glass Vials Powered by Stevanato Group’s EZ-fill® Technology
October 9, 2024
·
1 min read
Press Releases
Revolutionary lab-grown lung tissue set to transform therapies for respiratory diseases and organ transplantation
October 2, 2024
·
1 min read
Press Releases
Adnexus Biotechnologies Unveils Sutra(TM), a Game-Changing AI Platform for Drug Discovery and Infectious Disease Research
October 2, 2024
·
4 min read
Drug Development
Viatris launches (Pr)Viagra® ODF in Canada: a new oral dissolving film form of the erectile dysfunction treatment
September 30, 2024
·
6 min read
Press Releases
Tessellate BIO, Omico and CMRI announce a multi-year collaboration to accelerate discovery of synthetic lethal precision therapies to address ‘ALT’ cancers
September 30, 2024
·
5 min read
Press Releases
Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose Cohorts
September 27, 2024
·
5 min read
Press Releases
Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology
September 26, 2024
·
4 min read
Drug Development
New Study Demonstrates Power of Depixus’ Scalable Single Molecule Interactomics Platform to Accelerate RNA-Targeted Drug Development
September 25, 2024
·
2 min read
News
Health Canada Approves CardioFlux MCG for the Diagnosis of Myocardial Ischemia
September 20, 2024
·
3 min read
Drug Development
Astellas Receives Approval from the European Commission for VYLOY™ (zolbetuximab) in Combination with Chemotherapy for Advanced Gastric and Gastroesophageal Junction Cancer
September 20, 2024
·
15 min read
News
Axcelead Drug Discovery Partners Enters into Master Service Agreement for Drug Discovery Projects with Acadia Pharmaceuticals
September 19, 2024
·
2 min read
Press Releases
Drug Screening Market Size Projected to Reach USD 43.01 Billion By 2033
September 18, 2024
·
1 min read
Press Releases
Pendopharm announces public drug coverage plan listings for Octasa® (oral mesalamine)
September 11, 2024
·
3 min read
Drug Development
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
September 5, 2024
·
5 min read
Drug Development
Phesi Receives Frost & Sullivan’s Global Enabling Technology Leadership Award for Revolutionizing Clinical Development with Its Trial Accelerator Platform
September 4, 2024
·
5 min read
Drug Development
WINREVAIR® (sotatercept) is now authorized for use in Canada for Adults with Pulmonary Arterial Hypertension
September 4, 2024
·
4 min read
Drug Development
Poseida Therapeutics Presents New Case Study Demonstrating Reactivation of CAR-T Therapy with a T-Cell Engager in a Patient with Relapsed Multiple Myeloma
September 4, 2024
·
7 min read
Drug Development
Lungpacer Medical Announces PMA Submission for AeroPace® System
September 4, 2024
·
3 min read
Business
Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes
September 4, 2024
·
10 min read